MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

04 Mar 2026 Evaluate
Glenmark Pharmaceuticals has informed that, Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation. The press release in this regard is attached.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..